A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our MedTech Business Review Europe Advisory Board.

International Healthcare Media

Mario R. Nacinovich Jr., MSc, Director of Marketing, Americas, BVI Medical and Host of The Spotlight Series Podcast

From Activity to Impact: The New Standard in Healthcare Marketing

Mario R. Nacinovich Jr.

Mario R. Nacinovich Jr.

Digital transformation is no longer aspirational in healthcare marketing; it is expected. Yet many organizations still operate as if it were optional, mistaking channel activity for meaningful impact. Without integrated, data-driven systems, marketing does not drive growth; it supports it at best.

Throughout my career, I have seen this gap persist across organizations. Closing it often requires challenging entrenched thinking, overcoming inertia, and accelerating teams beyond their comfort zones. What began as HCP messaging and sales enablement has evolved into a far more complex mandate: performance marketing, omnichannel engagement, and real-world data must function as a unified system tied directly to business outcomes. Anything less is fragmentation.

Organizations that recognize this treat digital marketing as an enterprise capability. Those that do not continue to treat it as a function and fall behind.

From Campaigns to Connected Ecosystems

The traditional campaign model is no longer sufficient. Episodic bursts tied to launches or congresses may create visibility, but they rarely drive sustained behavior change. Healthcare decisions unfold over time, across multiple touchpoints and competing influences.

In one stalled product launch, the instinct was to increase spend. The real issue, however, was structural: disconnected engagement across the HCP and patient journey. By integrating CRM data, digital signals, and field intelligence, we rebuilt the model around decision points rather than tactics. Awareness, consideration, and adoption became distinct, measurable phases with aligned messaging.

The result was not incremental; it was a measurable shift in prescribing behavior and sales velocity.

Omnichannel is often misunderstood. It is not about scale; it is about precision. If you are not relevant at the moment of decision, you are effectively invisible.

Performance Marketing in a Regulated Environment

A persistent misconception is that regulation limits performance marketing. In reality, it exposes weak strategy.

Constraints force discipline. They eliminate vague targeting and demand clarity in messaging. In a recent specialty brand engagement, we moved away from broad awareness tactics and over-reliance on branded search. Instead, we focused on clinical intent, targeting long-tail queries aligned with real treatment decisions.

Media investment became dynamic rather than fixed, continuously optimized based on performance data and behavioral signals. All of this operated within compliant frameworks designed upfront to withstand medicallegal scrutiny. The result was a step change in both cost efficiency and conversion. Regulation is not the barrier; poor strategy is.

Marketing Automation as a Strategic Enabler

Marketing automation remains one of the most underutilized assets in healthcare. Too often, it is treated as a deployment tool rather than what it truly is: infrastructure for scalable, personalized engagement.

In one device portfolio initiative, we connected email, digital platforms, and rep-triggered activity into a unified system. Behavioral data, including content engagement, webinar participation, and site activity, continuously informed messaging, timing, and channel selection. Static campaigns were replaced with adaptive journeys.

Equally important, sales teams gained real-time visibility into customer behavior, enabling more relevant and timely interactions.

Co-creation is essential. Alignment determines adoption.

Automation should not replace human interaction; it should make it sharper in its connectivity and more effective.

Data-Driven Decision Making: From Insight to Accountability

Many organizations claim to be data driven. Few operate that way.

Dashboards are abundant; accountability is not. The real shift is not access to data, but the willingness to act on it. As my former colleague, Jean-Pierre Vasseur, president and chief executive officer of AVENIR GLOBAL, once noted to a room full of our partners, analytics are meaningless without intentional application.

Automation should not replace human interaction; it should make it sharper in its connectivity and more effective.

Across multiple engagements, we built systems linking engagement data, CRM inputs, and prescribing trends directly to outcomes. This eliminated ambiguity and forced clarity. Decisions were no longer based on consensus; they were grounded in evidence.

When marketing demonstrates measurable impact, it earns influence. Without it, it remains a cost center.

Customer Journey Optimization in Complex Markets

Healthcare journeys are often more complex than organizations acknowledge. Multiple stakeholders, conflicting incentives, long decision cycles, and inconsistent adherence all shape outcomes. Simplistic funnel models fail to capture this reality.

In a dry eye disease initiative, we mapped the true patient and HCP journey, identifying breakdowns in diagnosis, treatment progression, and adherence. Targeted, coordinated interventions across audiences led not only to improved engagement, but measurable gains in patient outcomes.

That is the standard. If marketing is not influencing care, it is not reaching its full potential.

From Alignment to Advantage

Alignment is not a one-time initiative; it is an operating discipline.

Orchestrate journeys, not channels; treat data as accountability, not just insight; recognize that regulation exposes weak; strategy, it does not limit performance; build automation with sales, not for them; tie every investment to measurable business impact.

The gap between leading and lagging healthcare organizations is widening. Leaders have operationalized transformation. Others remain stuck in pilot mode.

In a market moving this quickly, that is not a neutral position; it is a losing one.

A special thank you to my friend and former colleague, Michelle E. Hernandez, for her review and value-added comments in the development of this content.

The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.